 |
인쇄하기
취소
|
European Union approves blood thinner prasugrel
The European Commission granted marketing authorization for the blood thinner prasugrel, which will be sold in Europe under the brand name Efient, according to Eli Lilly and Daiichi Sankyo who developed prasugrel.
The drug is designed to prevent dangerous blood clots from forming in patients with acute heart problems, like heart attacks, who have had stents implanted in their arteries.
Th...
The drug is designed to prevent dangerous blood clots from forming in patients with acute heart problems, like heart attacks, who have had stents implanted in their arteries.
Th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.